Taubman Institute-Israel Initiative

The Taubman Institute has launched an initiative to establish collaborations between leading medical researchers in Michigan and their colleagues in Israel. The impetus behind the effort came from a trip to medical research facilities in Israel that Alfred Taubman took in 2008 with Institute Director Eva Feldman, M.D., Ph.D., and Institute Co-Chair Gayle Taubman Kalisman, Ed.D.

“We were very impressed by the ground-breaking research being done in Israel,” said Alfred Taubman. “And we immediately recognized the opportunities for collaboration between U of M and the talented scientists in Israel.”

To encourage the exchange of medical knowledge, the Institute has held two A. Alfred Taubman Lectureships at the University of Michigan, presented by preeminent Israeli stem cell researchers:

  • Miguel Weil, Ph.D., profession of life sciences at Tel Aviv University spoke on September 17, 2008. The title of his talk was “Mesenchymal Stem Cells in Regenerative Medicine.”
  • Benjamin Reubinoff, M.D., Ph.D., professor of neurology at Hadassah Medical Center presented his lecture on January 2009. One of the world’s pioneers in embryonic stem cell science, he spoke on the topic: “Human Embryonic Stem Cells: A Promising Therapy for Neurological Disorders.”

Both lectures were very well attended by U-M researchers. Preceding the talks, a reception was held for members of the University of Michigan and local Jewish communities. In addition, following Dr. Reubinoff’s lecture, the Greater Detroit Chapter of Hadassah sponsored a luncheon in his honor.

The Taubman Institute will continue to build relationships and joint projects with eminent Israeli scientists.

 


Help Us Make A Difference. Make A Donation That Could Save Lives.

Make A Gift

Connect/
Share/
follow/

Follow Us / Friend Us

Discovery-driven research that matters

phallodin

Taubman Scholar Dr. Charles Burant tests promising diabetes drug

TAK-875, a new treatment for type 2 diabetes, improves blood sugar control and is equally effective as glimepiride, but has a significantly lower risk of creating a dangerous drop in blood sugar, called hypoglycemia, according to a new study.

Read more

Taubman Institute leaders make the case for more doctor-scientist funding

 

The prestigious "Academic Medicine" journal has just published a new article authored by Taubman Institute senior management and Detroit-area attorney Scott Roberts.

The article explores the problematic gap between bench research and clinical application of new treatments or cures. 

Read more


Help Us Make A Difference. Make A Gift.

Leaders from the realms of business, academia and the community help to refine the Taubman Institute's vision, to monitor progress and to provide support, advice and counsel.

Meet the Leadership Advisory Board

Meet the Scientific Advisory Board

About Taubman Institute Video

In this video feature, Taubman Scholars explain why funding for high-risk research is so important to their work and to the discovery of promising cures and treatments.  

 

Stem cell surgery targets ALS Video

Patients glean hope from trial’s progress but wish it were faster

 

video-emerging-scholars-programDonors pitch in to keep brilliant science minds at U-M Video

Emerging Scholars program connects promising M.D.-researchers with philanthropists